Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    33.3%

    Based on 1 completed trials

    Completion Rate
    33%(1/3)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)
    Terminated
    2(67%)

    Phase Distribution

    Phase 2
    2
    67%

    Phase Distribution

    0

    Early Stage

    2

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 2Efficacy & side effects
    2(100.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    33.3%

    1 of 3 finished

    Non-Completion Rate

    66.7%

    2 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(1)
    Terminated(2)

    Detailed Status

    Terminated2
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    33.3%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 22 (100.0%)

    Trials by Status

    terminated267%
    completed133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    terminatedphase_2

    Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

    NCT00744341
    completedphase_2

    Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

    NCT00160134
    terminated

    Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

    NCT00568009

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT00744341Phase 2

    Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

    Terminated
    NCT00160134Phase 2

    Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

    Completed
    NCT00568009

    Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

    Terminated

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3